Global Custom Market Research Reports Provider Company

phone

Global Preclinical Imaging Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

  • Published Date: 08 Nov 2017
  • Number of Pages: 221
  • Category: Healthcare and Medical
  • Country: Global
Global Preclinical Imaging Market:

Global preclinical imaging market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for preclinical imaging is projected to reach US$ XX Mn by 2023.

Preclinical imaging is used during drug discovery process in live animals. Preclinical imaging used for monitoring the treatment regime responses helpful for obtaining the early indications of efficacy. Technological improvements and advances in in-vivo clinical study providing the new opportunities to understand the clearly molecular level of details. Major preclinical imaging is targeted for diseases such as autoimmune diseases, cancers, cardiovascular diseases, and neurological disorders and others.

Rise in the number of contract research organizations (CRO), innovations in the devices used for small imaging technological advancements, and increase in number of drug trials due to rise in the incidence and prevalence of chronic diseases such as rheumatoid arthritis, cancer, cardiovascular & neurological disorders are some of the factors bolstering the preclinical imaging market growth. The huge cost of equipment, lack of skilled personnel to handle the equipment and lack of proper infrastructure are hindering the growth of the market. Furthermore, restrictions on animal drug testing by animal rights organizations are the major factors hampering growth of the market.

The preclinical imaging market has been segmented by type of product, application, and end-user

Based on product type, preclinical imaging market segmented as:

Imaging Modalities
Single Photon emission computed tomography (SPECT)
Micro Computed Tomography (Micro-CT)
Magnetic Particle Imaging
Magnetic Resonance Imaging (MRI)
Optical Imaging
X-Ray Imaging
Positron Emission Tomography (PET)
Ultrasound
Others
Reagents and Kits

Based on of application, preclinical imaging market is segmented as:

Research and Development
Drug Discovery

Based on the end-user, preclinical imaging market is segmented as:

Biotech Companies
Pharmaceutical companies
Research institutes

Surge in adoption of sophisticated diagnostic technologies coupled with increased early diagnosis have expected to accelerate preclinical imaging market. According to American Cancer Society, 14.1 million new cancer cases were diagnosed and 8.2 million cancer deaths in 2012. Companies adopting product innovations to increase their market share. Currently, the most used imaging modalities are optical (fluorescence and bioluminescence), PET, and MRI. In addition, multi-modalities such as PET+CT and SPECT+CT are the most used imaging combinations. In-vivo imaging is increased usage in target identification, compound optimization and pre-Phase I study, and in the drug development process. Thus, it bridges the gap between in-vitro exploratory and in-vivo clinical research. Regions such as Latin America, Middle East, and Asia Pacific are witnessing an increase in foreign investments that is leading to greater revenue generation, for the market growth.

Geographically, global preclinical imaging market is segmented into Europe, North America, Latin America, Asia Pacific, and Middle East & Africa., North America expected to grow at significant rates due to increase in adoption of new technologies for better clinical outputs, technological advancements, and growing prevalence rates chronic diseases such as cardiovascular disease, cancer. According to the National Cancer Institute, in 2017, about 1,685,210 new cancer cases are expected to be diagnosed. Europe is expected to be another major market for preclinical imaging owing to factors such as increase in healthcare awareness among people and research and development activity for treating and preventing diseases. Asia-Pacific preclinical imaging market expected to show lucrative growth opportunity owing to cost-effective clinical and preclinical imaging services, coupled with favourable government policies.

Major players operating in preclinical imaging market include FUJIFILM Holdings Corporation (Japan), MR Solutions (U.K.), PerkinElmer Inc. (U.S.), Siemens Ltd (U.S.), Miltenyi Biotec (Germany), Aspect Imaging (Canada), MILabs B.V. (Netherlands), Bruker Corporation (U.S.), Mediso Ltd. (Hungary), TriFoil Imaging (U.S.), and Carestream Health (U.S.) to name a few.

In September 2016, Bruker Corporation signed an agreement to acquire the preclinical imaging business of Oncovision to increase their product portfolio

In March 2017, MR solutions introduced 9.4 tesla cryogen preclinical MRI imaging solution for cardiovascular sector

In February 2016, TriFoil Imaging installed InSyTe FLECT/CT Russias first 3D Optical imaging system at Novosibirsk

Report Outline:

The report provides granular level information about the market size, regional market share and forecast from 2017-2023
The report covers in-detail insights about the competitors overview, key findings and their key strategies
The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
The report tracks recent innovations, key developments and startups details that are working in the industry
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
Publisher Name : Precision Business Insights
1. Executive summary
2. Global Preclinical Imaging Market Introduction
2.1. Global Preclinical Imaging Market Taxonomy
2.2. Global Preclinical Imaging Market Definitions
2.2.1. Product Type
2.2.2. Application
2.2.3. End-User
3. Global Preclinical Imaging Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Preclinical Imaging Market Dynamics Factors Impact Analysis
3.6. Global Preclinical Imaging Market Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
3.7. Global Preclinical Imaging Market Recent Product Innovations
4. Global Preclinical Imaging Market Analysis, 2012 - 2016 and Forecast, 2017 2023
4.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. Global Preclinical Imaging Market, By Product Type, 2012 - 2016 and Forecast, 2017 - 2023
5.1. Imaging Modalities
5.1.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Single Photon Emission Computed Tomography (SPECT)
5.2.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Micro Computed Tomography (Micro-CT)
5.3.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Magnetic Particle Imaging
5.4.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Magnetic Resonance Imaging (MRI)
5.5.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Optical Imaging
5.6.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. X-Ray Imaging
5.7.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. Positron Emission Tomography (PET)
5.8.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
5.9. Ultrasound
5.9.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.9.3. Market Opportunity Analysis
5.10. Others
5.10.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
5.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.10.3. Market Opportunity Analysis
5.11. Reagents and Kits
5.11.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
5.11.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.11.3. Market Opportunity Analysis
5.12. Others
5.12.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
5.12.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.12.3. Market Opportunity Analysis
6. Global Preclinical Imaging Market, By Application, 2012 - 2016 and Forecast, 2017 - 2023
6.1. Researcha and Development
6.1.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Drug Discovery
6.2.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Preclinical Imaging Market Forecast, By End-User, 2012 - 2016 and Forecast, 2017 - 2023
7.1. Biotechnology Companies
7.1.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Pharma Companies
7.2.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Research Institutes
7.3.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Preclinical Imaging Market Forecast, By Region, 2012 - 2016 and Forecast, 2017 - 2023
8.1. North America
8.1.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Preclinical Imaging Market - Opportunity Analysis Index, By Product Type, By Application, By End-Use and Region, 2017 2023
9. North America Preclinical Imaging Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.1.1. Product Type Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1.1. Imaging Modalities
9.1.1.2. Single Photon emission computed tomography (SPECT)
9.1.1.3. Micro Computed Tomography (Micro-CT)
9.1.1.4. Magnetic Particle Imaging
9.1.1.5. Magnetic Resonance Imaging (MRI)
9.1.1.6. Optical Imaging
9.1.1.7. X-Ray Imaging
9.1.1.8. Positron Emission Tomography (PET)
9.1.1.9. Ultrasound
9.1.1.10. Others
9.1.1.11. Reagents and Kits
9.1.1.12. Others
9.1.2. Application Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.2.1. Research and Development
9.1.2.2. Drug Discovery
9.1.3. End-User Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.3.1. Biotech Companies
9.1.3.2. Pharmaceutical Companies
9.1.3.3. Research Institutes
9.1.4. Country Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.1.4.1. U.S.
9.1.4.2. Canada
9.1.5. North America Preclinical Imaging Market - Opportunity Analysis Index, By Product Type, By Application, By End-Use and Country, 2017 2023
9.1.6. North America Preclinical Imaging Market Dynamics Trends
10. Europe Preclinical Imaging Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
10.1.1. Product Type Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Imaging Modalities
10.1.1.2. Single Photon emission computed tomography (SPECT)
10.1.1.3. Micro Computed Tomography (Micro-CT)
10.1.1.4. Magnetic Particle Imaging
10.1.1.5. Magnetic Resonance Imaging (MRI)
10.1.1.6. Optical Imaging
10.1.1.7. X-Ray Imaging
10.1.1.8. Positron Emission Tomography (PET)
10.1.1.9. Ultrasound
10.1.1.10. Others
10.1.1.11. Reagents and Kits
10.1.1.12. Others
10.1.2. Application Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Research and Development
10.1.2.2. Drug Discovery
10.1.3. End-User Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.3.1. Biotech Companies
10.1.3.2. Pharmaceutical Companies
10.1.3.3. Research Institutes
10.1.4. Country Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.4.1. Germany
10.1.4.2. UK
10.1.4.3. France
10.1.4.4. Spain
10.1.4.5. Italy
10.1.4.6. Russia
10.1.4.7. Poland
10.1.4.8. Rest of Europe
10.1.5. Europe Preclinical Imaging Market - Opportunity Analysis Index, By Product Type, By Application, By End-User and Country, 2017 2023
10.1.6. Europe Preclinical Imaging Market Dynamics Trends
11. Asia-Pacific Preclinical Imaging Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
11.1.1. Product Type Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Imaging Modalities
11.1.1.2. Single Photon emission computed tomography (SPECT)
11.1.1.3. Micro Computed Tomography (Micro-CT)
11.1.1.4. Magnetic Particle Imaging
11.1.1.5. Magnetic Resonance Imaging (MRI)
11.1.1.6. Optical Imaging
11.1.1.7. X-Ray Imaging
11.1.1.8. Positron Emission Tomography (PET)
11.1.1.9. Ultrasound
11.1.1.10. Others
11.1.1.11. Reagents and Kits
11.1.1.12. Others
11.1.2. Application Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Research and Development
11.1.2.2. Drug Discovery
11.1.3. End-User Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Biotech Companies
11.1.3.2. Pharmaceutical Companies
11.1.3.3. Research Institutes
11.1.4. Country Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
11.1.4.1. Japan
11.1.4.2. China
11.1.4.3. India
11.1.4.4. ASEAN
11.1.4.5. Australia & New Zealand
11.1.4.6. Rest of Asia-Pacific
11.1.5. Asia-Pacific Preclinical Imaging Market - Opportunity Analysis Index, By Product Type, Application, End-User and Country, 2017 2023
11.1.6. Asia-Pacific Preclinical Imaging Market Dynamics Trends
12. Latin America Preclinical Imaging Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
12.1.1. Product Type Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Imaging Modalities
12.1.1.2. Single Photon emission computed tomography (SPECT)
12.1.1.3. Micro Computed Tomography (Micro-CT)
12.1.1.4. Magnetic Particle Imaging
12.1.1.5. Magnetic Resonance Imaging (MRI)
12.1.1.6. Optical Imaging
12.1.1.7. X-Ray Imaging
12.1.1.8. Positron Emission Tomography (PET)
12.1.1.9. Ultrasound
12.1.1.10. Others
12.1.1.11. Reagents and Kits
12.1.1.12. Others
12.1.2. Application Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Research and Development
12.1.2.2. Drug Discovery
12.1.3. End-User Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Biotech Companies
12.1.3.2. Pharmaceutical Companies
12.1.3.3. Research Institutes
12.1.4. Country Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Brazil
12.1.4.2. Mexico
12.1.4.3. Argentina
12.1.4.4. Venezuela
12.1.4.5. Rest of Latin America
12.1.5. Latin America Preclinical Imaging Market - Opportunity Analysis Index, By Product Type, Application, End-User and Country, 2017 2023
12.1.6. Latin America Preclinical Imaging Market Dynamics Trends
13. Middle East and Africa Preclinical Imaging Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
13.1.1. Product Type Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1.1. Imaging Modalities
13.1.1.2. Single Photon emission computed tomography (SPECT)
13.1.1.3. Micro Computed Tomography (Micro-CT)
13.1.1.4. Magnetic Particle Imaging
13.1.1.5. Magnetic Resonance Imaging (MRI)
13.1.1.6. Optical Imaging
13.1.1.7. X-Ray Imaging
13.1.1.8. Positron Emission Tomography (PET)
13.1.1.9. Ultrasound
13.1.1.10. Others
13.1.1.11. Reagents and Kits
13.1.1.12. Others
13.1.2. Application Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Research and Development
13.1.2.2. Drug Discovery
13.1.3. End-User Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Biotech Companies
13.1.3.2. Pharmaceutical Companies
13.1.3.3. Research Institutes
13.1.4. Country Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.4.1. Gulf Cooperation Council (GCC) Countries
13.1.4.2. Israel
13.1.4.3. South Africa
13.1.4.4. Rest of MEA
13.1.5. MEA Preclinical Imaging Market - Opportunity Analysis Index, By Product Type, Application, End-User and Country, 2017 2023
13.1.6. MEA Preclinical Imaging Market Dynamics Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. FUJIFILM Holdings Corporation (Japan)
14.2.2. MR Solutions (U.K.)
14.2.3. PerkinElmer Inc. (U.S.)
14.2.4. Siemens Ltd (U.S.)
14.2.5. Miltenyi Biotec (Germany)
14.2.6. Aspect Imaging (Canada)
14.2.7. MILabs B.V. (Netherlands)
14.2.8. Bruker Corporation (U.S.)
14.2.9. Mediso Ltd. (Hungary)
14.2.10. TriFoil Imaging (U.S.)
14.2.11. Carestream Health (U.S.)
15. Research Methodology
16. Key Assumptions and Acronyms


This report studies Basalt Fiber in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from

View Report

This report studies Newborn Screening Devices in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions,

View Report

This report studies Near Infrared Imaging in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions,

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports